Showing results (4241-4250 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 6, 2015
CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant TreatmentKarin Tamas, Urszula M Domanska, Tonnis H van Dijk, et al.Current Pharmaceutical Design|January 8, 2015
The long-term impact of early adversities on psychiatric disorders: focus on neuronal plasticityAlessia Luoni, Juliet Richetto, Giorgio Racagni, et al.Current Pharmaceutical Design|July 30, 2015
New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung CancerPaola Claudia Sacco, Paolo Maione, Antonio Rossi, et al.Current Pharmaceutical Design|December 2, 2014
Infection-associated biomarkers of inflammation in atherosclerosisEmil Kozarov, Kurt Huber, Johann WojtaCurrent Pharmaceutical Design|September 2, 2014
Catheter ablation of lone atrial fibrillationNebojsa M Mujovic, Milan M Marinkovic, Tatjana S Potpara, et al.Current Pharmaceutical Design|September 2, 2014
Endothelial (dys)function in lone atrial fibrillationMarija M Polovina, Gregory Y H Lip, Tatjana S PotparaCurrent Pharmaceutical Design|October 30, 2014
An emerging antiarrhythmic target: late sodium currentT Banyasz, N Szentandrássy, J Magyar, et al.Current Pharmaceutical Design|October 30, 2014
Future perspectives in the pharmacological treatment of atrial fibrillation and ventricular arrhythmias in heart failureIstván Baczko, István Leprán, Loránd Kiss, et al.Current Pharmaceutical Design|November 13, 2014
Chemistry and pharmacology of Angiotensin-converting enzyme inhibitorsMilosz Regulski, Katarzyna Regulska, Beata J Stanisz, et al.Current Pharmaceutical Design|October 15, 2014
Therapies targeting innate immunity for fighting inflammation in atherosclerosisItzhak Mendel, Niva Yacov, Dror Harats, et al.Pageof 1,008